接受HL-A配型相合的同胞供者骨髓的人类受者中移植物抗宿主病的临床表现。 - Suppr

Suppr

超能文献

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

作者信息

Glucksberg H, Storb R, Fefer A, Buckner C D, Neiman P E, Clift R A, Lerner K G, Thomas E D

出版信息

Transplantation. 1974 Oct;18(4):295-304. doi: 10.1097/00007890-197410000-00001.

DOI:10.1097/00007890-197410000-00001

PMID:4153799

Abstract

摘要

相似文献

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.接受HL-A配型相合的同胞供者骨髓的人类受者中移植物抗宿主病的临床表现。

Transplantation. 1974 Oct;18(4):295-304. doi: 10.1097/00007890-197410000-00001.

Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.使用人类白细胞抗原（HL-A）匹配的供体-受体同胞对进行异基因骨髓移植。

Trans Assoc Am Physicians. 1971;84:248-61.

Marrow transplants in aplastic anemia and leukemia.再生障碍性贫血和白血病的骨髓移植

Semin Hematol. 1974 Jul;11(3):353-67.

Bone marrow transplantation-clinical results and problems.骨髓移植——临床结果与问题

Blut. 1973 Nov;27(5):297-301. doi: 10.1007/BF01631040.

HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.采用环磷酰胺的同基因人白细胞抗原匹配的骨髓移植治疗再生障碍性贫血、急性白血病和淋巴肉瘤。

Transplant Proc. 1976 Dec;8(4):607-10.

Marrow transplantation for leukemia and aplastic anemia.用于白血病和再生障碍性贫血的骨髓移植。

Transplant Proc. 1976 Dec;8(4):603-5.

Marrow transplantation for aplastic anemia and acute leukemia.用于再生障碍性贫血和急性白血病的骨髓移植

Annu Rev Med. 1974;25:179-98. doi: 10.1146/annurev.me.25.020174.001143.

Marrow transplantation for the treatment of aplastic anemia and acute leukemia.用于治疗再生障碍性贫血和急性白血病的骨髓移植。

Transplant Proc. 1976 Jun;8(2 Suppl 1):159-63.

The use of cyclophosphamide for clinical marrow transplantation.环磷酰胺在临床骨髓移植中的应用。

Transplant Proc. 1972 Dec;4(4):559-64.

Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.对28例接受来自 HLA 同型同胞骨髓移植的人类患者的细胞抑制和血清阻断因子的研究。

J Immunol. 1977 May;118(5):1799-805.

引用本文的文献

Gut Microbiome and Metabolome Dynamics as Predictors of Clinical Outcomes in Hematopoietic Stem Cell Transplantation.肠道微生物组和代谢组动力学作为造血干细胞移植临床结局的预测指标

MedComm (2020). 2025 Aug 18;6(9):e70334. doi: 10.1002/mco2.70334. eCollection 2025 Sep.

Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center, real-world experience.鲁索替尼联合类固醇用于造血干细胞移植后一线治疗急性移植物抗宿主病的疗效和安全性：一项单中心真实世界经验

Front Immunol. 2025 Jul 14;16:1621708. doi: 10.3389/fimmu.2025.1621708. eCollection 2025.

Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMT.移植前诱导周期对急性淋巴细胞白血病患者移植后结局的影响：来自欧洲血液与骨髓移植协会急性白血病工作组的一项研究

Bone Marrow Transplant. 2025 Jul 3. doi: 10.1038/s41409-025-02669-0.

High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.第90天时自然杀伤细胞计数高预示着T细胞去除的异基因干细胞移植后无事件患者的生存率提高。

Front Immunol. 2025 Jun 18;16:1577924. doi: 10.3389/fimmu.2025.1577924. eCollection 2025.

Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics.通过减少全身免疫抑制改变T细胞嵌合动态，提高小儿小肠移植后移植物抗宿主病的生存率。

Transplant Direct. 2025 Jun 27;11(7):e1830. doi: 10.1097/TXD.0000000000001830. eCollection 2025 Jul.

A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.一项关于移植后环磷酰胺和阿巴西普预防移植物抗宿主病的前瞻性临床试验。

Blood Adv. 2025 Aug 26;9(16):4336-4344. doi: 10.1182/bloodadvances.2024015094.

Efficacy and safety of rabbit ATLG and ATG in allogeneic hematopoietic stem cell transplantation for children with acquired severe aplastic anemia.兔抗胸腺细胞球蛋白（ATLG）和抗胸腺细胞球蛋白（ATG）在儿童获得性重型再生障碍性贫血异基因造血干细胞移植中的疗效及安全性

Ann Hematol. 2025 Jun 19. doi: 10.1007/s00277-025-06461-4.

Modern-Era Challenges in the Clinical Management of Graft-Versus-Host Disease.移植物抗宿主病临床管理中的现代挑战

Adv Exp Med Biol. 2025;1475:103-128. doi: 10.1007/978-3-031-84988-6_6.

Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience.第二次异基因干细胞移植治疗移植物失败或移植物功能不良后的结局：单中心经验

Stem Cell Rev Rep. 2025 Jun 5. doi: 10.1007/s12015-025-10903-x.

Busulfan-cyclophosphamide vs fludarabine-busulfan for allogeneic transplant in acute myeloid leukemia.白消安-环磷酰胺与氟达拉滨-白消安用于急性髓系白血病异基因移植的比较

Future Oncol. 2025 Jun;21(15):1887-1894. doi: 10.1080/14796694.2025.2507563. Epub 2025 May 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验